ATMPs – Thinking Big, Inclusive and Beyond Rare Disease!
Current medical treatments, particularly in common diseases, often rely on chronic medication, which has its limitations. To promote healthier aging and enhance quality of life, the development of sustainable and regenerative therapies is crucial. Challenges in demonstrating proof of principle and financial constraints post-proof of principle have impeded the clinical translation and wider adoption of advanced therapies.
With the RegMed Forum we aim to identify those shortcomings that currently block or hinder advanced and regenerative therapies to become leading strategies in health care. We believe that a patient-centric view should be at the core of our discussion and, thus, the forum brings together all stakeholders involved from patient representatives, healthcare providers, regulatory authorities, scientists, start-ups and big pharma. They will share their expertise and opinions in talks, panel discussions and dedicated round tables. Furthermore, there will be plenty of networking opportunities aiming to reach a consensus understanding on the essential patient-centric outcome measures and the requirements of a patient-centric view. Such way, the implementation of advanced therapies could prove effective despite their sometimes higher initial costs.
What to expect?
- Talks & panel discussions with different stakeholders.
- Round table discussions in breakout-sessions on specific topics.
- Plenty of onsite networking opportunity with industry exhibition.
Who will be attending?
Patient representatives, healthcare providers, regulatory authorities, scientists, start-ups and big pharma from Germany and beyond interested in developing essential outcome measures and requirements in a patient-centric view that could help to support pre-clinical and clinical work to enable broader applications of advanced therapies in various indications.
Participation is free of charge.
About the event
The BIH Center for Regenerative Therapies (BCRT), Charité – Universitätsmedizin Berlin and the Cluster Health Capital Berlin-Brandenburg are jointly organizing the international RegMed Forum since 2014.
This event series provides the opportunity to hear and discuss science in the field of regenerative medicine - from basic research to clinical implementation and industrialization. In addition to a comprehensive scientific program there will be opportunities to network and discuss with industry and research groups in the regenerative medicine field.
About the BIH Center for Regenerative Therapies (BCRT)
The research landscape of Berlin-Brandenburg has developed into one of the most important international clusters for regenerative medicine. A major contribution to this development has been the BCRT - an interdisciplinary clinical translational center operated by the Berlin Institute of Health at Charité (BIH).
The primary focus of the BCRT is the development of novel methods to promote endogenous regeneration to address acute and chronic diseases of the immune, musculoskeletal and cardiovascular systems. This includes using cells, biomaterials and biological factors or a combination thereof to provide long-term and possibly curative treatments. With respect to the development and implementation of innovative therapies and products from the BCRT, the first potential success story for a novel regenerative product is starting to emerge. Virus-specific T-cell products for long-term protection against serious infections are being evaluated in onsite clinical studies for treatment of patients with a weakened immune system. Following the concept of refined translation, i.e. iterative incorporation of (pre-)clinical research findings into product development, and the use of biomarkers, the BCRT is actively pushing further treatment concepts towards clinical evaluation. This also includes new cell-based therapies for heart disease and muscle injuries.
About the Cluster Health Capital
The German capital region is one of the world's leading locations for the healthcare industry, healthcare, and the life sciences. Leading global companies, renowned scientists, first-class hospitals, innovative start-ups, and specialists from all over the world work together in Berlin-Brandenburg each day to deliver the very best goods and services for the regional and global healthcare markets.
The cluster management team at Berlin Partner for Business and Technology and Brandenburg Economic Development Corporation (WFBB) drives networking and the technology transfer in the region and supports international companies interested in relocating to the German capital region.
To protect yourself and others from respiratory infections, it may be advisable to wear a mask at the event. If you show signs of a respiratory infection, we kindly ask you to test yourself for a SARS-CoV-2 infection in advance.
We are looking forward to meeting you on November 23, 2023 in Berlin!